Why Did Stan Druckenmiller Sell Broadcom Stock?
In Q3, legendary macro investor Stan Druckenmiller sold his entire…
Sell
49
FBLG Quote, Financials, Valuation and Earnings
Last price:
$0.33
Seasonality move
:
-54.09%
Day range:
$0.26 - $0.37
52-week range:
$0.22 - $2.28
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
141.57x
Volume:
6M
Avg. volume:
2.9M
1-year change:
-84.78%
Market cap:
$17.7M
Revenue:
--
EPS (TTM):
-$0.48
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | $94K | $437K | $573K | |
| Gross Profit | -- | -- | -$94K | -$437K | -$573K | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | $521K | $1.1M | $2.3M | $4.3M | |
| Selling, General & Admin | -- | $1.1M | $3.3M | $6.5M | $9.2M | |
| Other Inc / (Exp) | -- | -- | -- | -$7.4M | $2.3M | |
| Operating Expenses | -- | $1.6M | $4.4M | $8.5M | $13.2M | |
| Operating Income | -- | -$1.6M | -$4.5M | -$8.9M | -$13.7M | |
| Net Interest Expenses | -- | $4K | $654K | $147K | $20K | |
| EBT. Incl. Unusual Items | -- | -$1.6M | -$5.1M | -$16.5M | -$11.2M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -- | -$1.6M | -$5.1M | -$16.5M | -$11.2M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | -$1.6M | -$5.1M | -$16.5M | -$11.2M | |
| Basic EPS (Cont. Ops) | -- | -$0.05 | -$0.16 | -$0.68 | -$0.34 | |
| Diluted EPS (Cont. Ops) | -- | -$0.05 | -$0.16 | -$0.68 | -$0.34 | |
| Weighted Average Basic Share | -- | $32.5M | $32.5M | $28.2M | $32.9M | |
| Weighted Average Diluted Share | -- | $32.5M | $32.5M | $28.2M | $32.9M | |
| EBITDA | -- | -$1.6M | -$4.4M | -$8.5M | -$13.2M | |
| EBIT | -- | -$1.6M | -$4.5M | -$8.9M | -$13.7M | |
| Revenue (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Reported) | -- | -$1.6M | -$4.5M | -$8.9M | -$13.7M | |
| Operating Income (Adjusted) | -- | -$1.6M | -$4.5M | -$8.9M | -$13.7M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | $112K | $143K | $231K | |
| Gross Profit | -- | -- | -$112K | -$143K | -$231K | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | $348K | $561K | $1.2M | $2.8M | |
| Selling, General & Admin | -- | $993K | $1.5M | $2.1M | $2.2M | |
| Other Inc / (Exp) | -- | -- | -$141K | $2.8M | -- | |
| Operating Expenses | -- | $1.3M | $1.9M | $3.2M | $4.8M | |
| Operating Income | -- | -$1.3M | -$2.1M | -$3.4M | -$5M | |
| Net Interest Expenses | -- | $221K | -- | $5K | -- | |
| EBT. Incl. Unusual Items | -- | -$1.6M | -$2.2M | -$500K | -$5.8M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -- | -- | -$2.2M | -$500K | -$5.8M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | -$1.6M | -$2.2M | -$500K | -$5.8M | |
| Basic EPS (Cont. Ops) | -- | -$0.05 | -$0.07 | -$0.01 | -$0.13 | |
| Diluted EPS (Cont. Ops) | -- | -$0.05 | -$0.07 | -$0.01 | -$0.13 | |
| Weighted Average Basic Share | -- | $32.5M | $32.5M | $33.5M | $43.1M | |
| Weighted Average Diluted Share | -- | $32.5M | $32.5M | $33.5M | $43.1M | |
| EBITDA | -- | -$1.3M | -$1.9M | -$3.2M | -$4.8M | |
| EBIT | -- | -$1.3M | -$2.1M | -$3.4M | -$5M | |
| Revenue (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Reported) | -- | -$1.3M | -$2.1M | -$3.4M | -$5M | |
| Operating Income (Adjusted) | -- | -$1.3M | -$2.1M | -$3.4M | -$5M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | $401K | $550K | $751K | |
| Gross Profit | -- | -- | -$401K | -$550K | -$751K | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | $1.9M | $3.8M | $7.9M | |
| Selling, General & Admin | -- | $993K | $3.3M | $8.6M | $9.8M | |
| Other Inc / (Exp) | -- | -- | -$213K | -$5.4M | -- | |
| Operating Expenses | -- | -- | $7.3M | $12M | $17M | |
| Operating Income | -- | -- | -$7.7M | -$12.5M | -$17.8M | |
| Net Interest Expenses | -- | $221K | $366K | $15K | $6K | |
| EBT. Incl. Unusual Items | -- | -$1.6M | -$8.3M | -$17.8M | -$18.5M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -- | -- | -$8.3M | -$17.8M | -$18.5M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | -- | -$8.3M | -$17.8M | -$18.5M | |
| Basic EPS (Cont. Ops) | -- | -- | -$0.33 | -$0.59 | -$0.48 | |
| Diluted EPS (Cont. Ops) | -- | -$0.05 | -$0.33 | -$0.59 | -$0.48 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -- | -- | -$7.3M | -$12M | -$17M | |
| EBIT | -- | -- | -$7.7M | -$12.5M | -$17.8M | |
| Revenue (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Reported) | -- | -- | -$7.7M | -$12.5M | -$17.8M | |
| Operating Income (Adjusted) | -- | -- | -$7.7M | -$12.5M | -$17.8M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | $307K | $420K | $598K | |
| Gross Profit | -- | -- | -$307K | -$420K | -$598K | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | $348K | $1.6M | $3M | $6.6M | |
| Selling, General & Admin | -- | $993K | $3.3M | $6.9M | $7.4M | |
| Other Inc / (Exp) | -- | -- | -$213K | $1.8M | -$752K | |
| Operating Expenses | -- | $1.3M | $6.1M | $9.6M | $13.5M | |
| Operating Income | -- | -$1.3M | -$6.4M | -$10M | -$14.1M | |
| Net Interest Expenses | -- | $221K | $146K | $14K | -- | |
| EBT. Incl. Unusual Items | -- | -$1.6M | -$6.8M | -$8.1M | -$15.4M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -- | -- | -$6.8M | -$8.1M | -$15.4M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | -$1.6M | -$6.8M | -$8.1M | -$15.4M | |
| Basic EPS (Cont. Ops) | -- | -$0.05 | -$0.29 | -$0.25 | -$0.39 | |
| Diluted EPS (Cont. Ops) | -- | -$0.05 | -$0.29 | -$0.25 | -$0.39 | |
| Weighted Average Basic Share | -- | $32.5M | $97.7M | $99M | $118.4M | |
| Weighted Average Diluted Share | -- | $32.5M | $97.7M | $99M | $118.4M | |
| EBITDA | -- | -$1.3M | -$6.1M | -$9.6M | -$13.5M | |
| EBIT | -- | -$1.3M | -$6.4M | -$10M | -$14.1M | |
| Revenue (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Reported) | -- | -$1.3M | -$6.4M | -$10M | -$14.1M | |
| Operating Income (Adjusted) | -- | -$1.3M | -$6.4M | -$10M | -$14.1M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | -- | $407K | $2.3M | $9.2M | $14M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | $37K | $29K | $36K | $225K | |
| Other Current Assets | -- | $24K | $30K | $16K | $18K | |
| Total Current Assets | -- | $468K | $2.6M | $9.2M | $14.2M | |
| Property Plant And Equipment | -- | -- | $2.2M | $2.6M | $2.2M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | -- | $468K | $4.8M | $11.8M | $22.1M | |
| Accounts Payable | -- | $229K | $493K | $1.4M | $2.7M | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | $1.3M | $5.5M | -- | $9.2M | |
| Current Portion Of Capital Lease Obligations | -- | -- | $326K | $362K | $401K | |
| Other Current Liabilities | -- | -- | $538K | $7.2M | $460K | |
| Total Current Liabilities | -- | $1.8M | $7.1M | $9.2M | $12.7M | |
| Long-Term Debt | -- | -- | $1.7M | $1.4M | $984K | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | -- | $1.8M | $8.8M | $10.6M | $19.4M | |
| Common Stock | -- | -- | $1K | $1K | -- | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -- | -$1.3M | -$4M | $1.3M | $2.7M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | -- | -$1.3M | -$4M | $1.3M | $2.7M | |
| Total Liabilities and Equity | -- | $468K | $4.8M | $11.8M | $22.1M | |
| Cash and Short Terms | -- | $407K | $2.3M | $9.2M | $14M | |
| Total Debt | -- | -- | $1.7M | $1.4M | $984K | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | -- | -- | $10.8M | $7.8M | $4.9M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | $27K | $353K | $373K | |
| Other Current Assets | -- | -- | $121K | $18K | -- | |
| Total Current Assets | -- | -- | $10.9M | $8.2M | $5.2M | |
| Property Plant And Equipment | -- | -- | $2.4M | $2.3M | $3.5M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | -- | -- | $13.3M | $10.5M | $8.7M | |
| Accounts Payable | -- | -- | $755K | $1.2M | $1.1M | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | $353K | $392K | -- | |
| Other Current Liabilities | -- | -- | -- | $3.1M | -- | |
| Total Current Liabilities | -- | -- | $1.3M | $6.7M | $6.7M | |
| Long-Term Debt | -- | -- | $1.4M | $1.1M | $1.9M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | -- | -- | $2.8M | $7.7M | $8.6M | |
| Common Stock | -- | -- | $1K | -- | -- | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | $940K | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | -- | -- | $10.5M | $2.7M | $125K | |
| Total Liabilities and Equity | -- | -- | $13.3M | $10.5M | $8.7M | |
| Cash and Short Terms | -- | -- | $10.8M | $7.8M | $4.9M | |
| Total Debt | -- | -- | $1.4M | $1.1M | $1.9M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -$1.6M | -$5.1M | -$16.5M | -$11.2M | |
| Depreciation & Amoritzation | -- | -- | $94K | $437K | $573K | |
| Stock-Based Compensation | -- | -- | $265K | $1.8M | $2.2M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -$1.4M | -$4.1M | -$6.4M | -$11.9M | |
| Capital Expenditures | -- | -- | -- | $495K | $184K | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -$495K | -$184K | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | $2.3M | $4.3M | $300K | $9.4M | |
| Long-Term Debt Repaid | -- | -$750K | -$525K | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | $292K | -- | -$2.6M | -- | |
| Cash From Financing | -- | $1.8M | $5.9M | $13.8M | $16.9M | |
| Beginning Cash (CF) | -- | $407K | $2.3M | $9.2M | $14M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | $407K | $1.9M | $6.9M | $4.8M | |
| Ending Cash (CF) | -- | $814K | $4.1M | $16.1M | $18.8M | |
| Levered Free Cash Flow | -- | -$1.4M | -$4.1M | -$6.9M | -$12.1M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -$2.2M | -$500K | -$5.8M | |
| Depreciation & Amoritzation | -- | -- | $112K | $143K | $231K | |
| Stock-Based Compensation | -- | -- | $437K | $572K | $704K | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | -$1.1M | -$2.6M | -$4M | |
| Capital Expenditures | -- | -- | $413K | $11K | $6K | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -$413K | -$11K | -$6K | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -$172K | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | $940K | $4.5M | -- | |
| Beginning Cash (CF) | -- | -- | $10.8M | $7.8M | $4.9M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -$612K | $1.9M | -$4M | |
| Ending Cash (CF) | -- | -- | $10.2M | $9.7M | $889K | |
| Levered Free Cash Flow | -- | -- | -$1.6M | -$2.6M | -$4M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -$8.3M | -$17.8M | -$18.5M | |
| Depreciation & Amoritzation | -- | -- | $401K | $550K | $751K | |
| Stock-Based Compensation | -- | -- | $1.4M | $2.1M | $2.5M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | -$6M | -$10.4M | -$16.3M | |
| Capital Expenditures | -- | -- | $493K | $87K | $361K | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -$493K | -$87K | -$361K | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | $574K | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -$459K | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | $15.9M | $7.6M | $13.7M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | $9.5M | -$2.9M | -$3M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | -$6.5M | -$10.5M | -$16.7M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -$6.8M | -$8.1M | -$15.4M | |
| Depreciation & Amoritzation | -- | -- | $307K | $420K | $598K | |
| Stock-Based Compensation | -- | -- | $1.3M | $1.7M | $2M | |
| Change in Accounts Receivable | -- | -- | -$275K | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | -$4.8M | -$8.8M | -$13.2M | |
| Capital Expenditures | -- | -- | $493K | $85K | $262K | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -$493K | -$85K | -$262K | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | $300K | $574K | $4.4M | |
| Long-Term Debt Repaid | -- | -- | -- | -$459K | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -$2.6M | -- | -- | |
| Cash From Financing | -- | -- | $13.8M | $7.6M | $4.4M | |
| Beginning Cash (CF) | -- | -- | $10.8M | $22M | $22.4M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | $8.5M | -$1.3M | -$9.1M | |
| Ending Cash (CF) | -- | -- | $10.2M | $20.6M | $13.3M | |
| Levered Free Cash Flow | -- | -- | -$5.3M | -$8.9M | -$13.5M | |
Get FBLG Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
FBLG
Sector
P/E ratio
--
24.20x
PEG ratio
-0.03x
-0.01x
P/B ratio
141.57x
1.84x
Price / LTM sales
--
1.60x
Growth Metrics
FBLG
Sector
Revenue growth
--
4.62%
Earnings growth
-800.67%
10.88%
Revenue (5-year growth)
--
6.45%
Earnings forecast
-$0.10
-$0.19
Profitability
FBLG
Sector
Profitability FY 2024
-$573K
$3.6M
Return on invested capital
-201.42%
-32.02%
Return on assets
-138.76%
-28.31%
Return on equity
-1050.36%
-38%
Earnings Date
Last Earnings Date
Aug
14
Next Earnings Date
Jan
9
Estimated Next Earnings Date
Apr
10
Balance Sheet
FBLG
Sector
Total cash
$4.9M
$26.1M
Short term investments
--
$25.7M
Total assets
$22.1M
$76.6M
Long term debt
$1.9M
$3.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Is CoreWeave Stock Down So Much?
AI cloud computing business CoreWeave (NASDAQ:CRWV) has been through a…
Why Did Stan Druckenmiller Buy MercadoLibre Stock?
In Q3, billionaire Stan Druckenmiller bought about 4,620 shares of…
Stock Ideas
Buy
59
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
65
Is GOOG Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 40x
Buy
51
Is GOOGL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 40x
Alerts
Buy
70
RGC alert for Jan 8
Regencell Bioscience Holdings Ltd. [RGC] is down 21.5% over the past day.
Buy
64
RVMD alert for Jan 8
Revolution Medicines, Inc. [RVMD] is up 4.61% over the past day.
Sell
38
CRNX alert for Jan 8
Crinetics Pharmaceuticals, Inc. [CRNX] is down 0.23% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
